McKesson Corporation (MCK) — Analysis Summary
McKesson Corporation (MCK) has a market cap of $104.16B with year-over-year revenue growth of +12.4%. Net margin stands at 1.2%. The stock trades at a P/E ratio of 21.9.
Key Takeaways
- Revenue changed +12.4% year-over-year
- Net margin of 1.2%
- P/E ratio of 21.9
Compared to other companies in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector, MCK posted revenue growth of +12.4% and trades at a P/E of 21.9.
McKesson Corporation (MCK)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Shareholder equity is negative, which can signal balance-sheet stress.
Current ratio at 0.85x — current liabilities exceed current assets
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Employees
43,000
Headquarters
IRVING, TX
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$3.76
Dividend Yield
0.42%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.